Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Corcept Therapeutics (CORT) Leases (2019 - 2026)

Corcept Therapeutics (CORT) has disclosed Leases for 8 consecutive years, with $7.2 million as the latest value for Q1 2026.

  • For Q1 2026, Leases rose 39.81% year-over-year to $7.2 million; the TTM value through Mar 2026 reached $7.2 million, up 39.81%, while the annual FY2025 figure was $4.6 million, 13.92% down from the prior year.
  • Leases hit $7.2 million in Q1 2026 for Corcept Therapeutics, up from $4.6 million in the prior quarter.
  • Across five years, Leases topped out at $7.2 million in Q1 2026 and bottomed at $61000.0 in Q1 2024.
  • Average Leases over 5 years is $3.1 million, with a median of $2.8 million recorded in 2022.
  • Year-over-year, Leases tumbled 89.62% in 2023 and then skyrocketed 8337.7% in 2025.
  • Corcept Therapeutics' Leases stood at $1.1 million in 2022, then crashed by 89.5% to $120000.0 in 2023, then surged by 4336.67% to $5.3 million in 2024, then decreased by 13.92% to $4.6 million in 2025, then surged by 57.02% to $7.2 million in 2026.
  • According to Business Quant data, Leases over the past three periods came in at $7.2 million, $4.6 million, and $4.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.